glp 1 alzheimer's Popular obesity drug fails in hotly anticipated trials | Science π§ β¨ New research is uncovering
Description
Lastly, it would be beneficial to conduct research on the possible synergistic anti-inflammatory benefits of combination therapy (GLP-1 RAs with SGLT2 inhibitors, nonsteroidal MRA, or targeted anti-inflammatory drugs)
However, the larger issue is that many people see the new drugs as a quick-fix solution
Biomarker qualification: evidentiary framework
Be sure to tell your prescriber about any side effects you experience, especially if theyre severe or persistent
